About

Corporate Overview

History:

Founded in 2016; successfully uplisted to Nasdaq in December 2018; Headquarters in Freehold, New Jersey; approx. 60 FTEs (including subsidiaries)

Core Technology Platforms:

  • Cellular Immunotherapies
    • Including Chimeric Antigen Receptor (CAR)-T, RNA-based FLASH-CARTM and AVA-TrapTM
  • Precision Diagnostics / Clinical Laboratory Services